Brief: Eledon Pharmaceuticals Announces Up To $185 Million Financing To Advance Tegoprubart Kidney Transplantation Clinical Trials

Eledon Pharmaceuticals

01/05/2023 13:38

Eledon Pharmaceuticals Inc  ELDN.O :
    * ELEDON PHARMACEUTICALS ANNOUNCES UP TO $185 MILLION
FINANCING TO
ADVANCE TEGOPRUBART KIDNEY TRANSPLANTATION CLINICAL TRIALS
    * ELEDON PHARMACEUTICALS INC - PURCHASE IS COMPRISED OF AN
INITIAL
UPFRONT FINANCING OF $35 MILLION IN EXCHANGE FOR 15.2 MILLION
COMMON SHARES
    * ELEDON PHARMACEUTICALS INC -  PURCHASE IS COMPRISED OF
ADDITIONAL $105 MILLION IN MANDATORY TRANCHE FINANCING, SUBJECT
TO ACHIEVING SPECIFIED MILESTONES
    * ELEDON PHARMACEUTICALS INC - CO WILL HAVE POTENTIAL TO
RECEIVE
$45 MILLION UPON FULL EXERCISE OF WARRANTS BEING ISSUED IN
CONNECTION WITH AGREEMENT
    * ELEDON PHARMACEUTICALS INC - FINANCING IS BEING LED BY BVF
PARTNERS LP AND ARMISTICE CAPITAL

Source text for Eikon:  ID:nGNX1bZykC 
Further company coverage:  ELDN.O